JP2019535265A5 - - Google Patents

Download PDF

Info

Publication number
JP2019535265A5
JP2019535265A5 JP2019524951A JP2019524951A JP2019535265A5 JP 2019535265 A5 JP2019535265 A5 JP 2019535265A5 JP 2019524951 A JP2019524951 A JP 2019524951A JP 2019524951 A JP2019524951 A JP 2019524951A JP 2019535265 A5 JP2019535265 A5 JP 2019535265A5
Authority
JP
Japan
Prior art keywords
population
cells
days
item
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019524951A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019535265A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/061541 external-priority patent/WO2018090002A1/en
Publication of JP2019535265A publication Critical patent/JP2019535265A/ja
Publication of JP2019535265A5 publication Critical patent/JP2019535265A5/ja
Priority to JP2022072292A priority Critical patent/JP2022090133A/ja
Pending legal-status Critical Current

Links

JP2019524951A 2016-11-14 2017-11-14 幹細胞由来シュワン細胞 Pending JP2019535265A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022072292A JP2022090133A (ja) 2016-11-14 2022-04-26 幹細胞由来シュワン細胞

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662421816P 2016-11-14 2016-11-14
US62/421,816 2016-11-14
PCT/US2017/061541 WO2018090002A1 (en) 2016-11-14 2017-11-14 Stem cell derived schwann cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022072292A Division JP2022090133A (ja) 2016-11-14 2022-04-26 幹細胞由来シュワン細胞

Publications (2)

Publication Number Publication Date
JP2019535265A JP2019535265A (ja) 2019-12-12
JP2019535265A5 true JP2019535265A5 (https=) 2021-04-08

Family

ID=62110088

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019524940A Pending JP2019535263A (ja) 2016-11-14 2017-11-14 幹細胞由来シュワン細胞を使用する薬物発見のための方法
JP2019524951A Pending JP2019535265A (ja) 2016-11-14 2017-11-14 幹細胞由来シュワン細胞
JP2022022796A Pending JP2022059056A (ja) 2016-11-14 2022-02-17 幹細胞由来シュワン細胞を使用する薬物発見のための方法
JP2022072292A Pending JP2022090133A (ja) 2016-11-14 2022-04-26 幹細胞由来シュワン細胞

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019524940A Pending JP2019535263A (ja) 2016-11-14 2017-11-14 幹細胞由来シュワン細胞を使用する薬物発見のための方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022022796A Pending JP2022059056A (ja) 2016-11-14 2022-02-17 幹細胞由来シュワン細胞を使用する薬物発見のための方法
JP2022072292A Pending JP2022090133A (ja) 2016-11-14 2022-04-26 幹細胞由来シュワン細胞

Country Status (9)

Country Link
US (2) US20190331666A1 (https=)
EP (2) EP3538115A4 (https=)
JP (4) JP2019535263A (https=)
KR (1) KR20190077095A (https=)
CN (2) CN110249047A (https=)
AU (2) AU2017357076A1 (https=)
CA (2) CA3043226A1 (https=)
IL (2) IL266524A (https=)
WO (2) WO2018090006A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL272246B2 (en) 2017-07-28 2026-01-01 Applied Therapeutics Inc History of 2-(4-oxo/thioketone/azo-3-((substituted)benzo[d]thiazol-2-yl)methyl)- 3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid for use as an aldose reductase inhibitor for the treatment of galactosemia or prevention of galactosemia-related complications
US11511136B2 (en) * 2017-11-17 2022-11-29 The Research Foundation For The State University Of New York Method for treating damaged peripheral nerves using x-ray microbeam irradiation
CA3084259A1 (en) * 2017-12-04 2019-06-13 The Administrators Of The Tulane Educational Fund Cell systems using spheroids and methods of making and using the same
US11845989B2 (en) 2019-01-23 2023-12-19 Regeneron Pharmaceuticals, Inc. Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
MX2021008797A (es) 2019-01-23 2022-01-31 Regeneron Pharma Tratamiento de afecciones oftalmicas con inhibidores de proteinas relacionadas a angiopoyetina 7 (angptl7).
CA3132136A1 (en) 2019-04-01 2020-10-08 Andrew Wasmuth Inhibitors of aldose reductase
JP2022531466A (ja) 2019-05-07 2022-07-06 ユニバーシティ オブ マイアミ 遺伝性ニューロパチーおよび関連障害の処置および検出
CN110157660A (zh) * 2019-06-10 2019-08-23 西安飞如生物科技有限公司 诱导成纤维细胞分泌抗菌肽的诱导培养基和方法、成纤维细胞及应用
JPWO2021166984A1 (https=) * 2020-02-20 2021-08-26
EP3929281A1 (en) 2020-06-24 2021-12-29 Fachhochschule Technikum Wien Cell construct comprising schwann cells or schwann cell-like cells and a biocompatible matrix
US11865134B2 (en) 2021-02-26 2024-01-09 Regeneron Pharmaceuticals, Inc. Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitors
EP4355864A4 (en) * 2021-06-18 2025-04-23 Memorial Sloan Kettering Cancer Center Methods of generating sacral neural crest lineages and uses thereof
CA3265079A1 (en) * 2022-08-16 2024-02-22 The Regents Of The University Of California CELLULAR COMPOSITIONS AND THEIR METHODS OF USE
WO2025170529A1 (en) 2024-02-09 2025-08-14 Hedlund Eva A method for deriving a multipotent neuromesodermal progenitor cell and/or daughter lineages, and related compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023568A2 (en) * 1998-10-06 2000-04-27 Albert Einstein College Of Medicine Of Yeshiva University Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells
CN101066472B (zh) * 2007-04-18 2010-05-19 中国人民解放军第二军医大学 组织工程化周围神经移植体及其制备方法
US8709805B2 (en) * 2009-08-07 2014-04-29 Kyoto University Canine iPS cells and method of producing same
WO2011046189A1 (ja) * 2009-10-15 2011-04-21 国立大学法人京都大学 神経変性疾患のモデル細胞、その製造方法及びその用途
CN102191217A (zh) * 2010-03-12 2011-09-21 上海市第一人民医院 一种诱导脐带间充质干细胞分化为类神经细胞的方法
DK3578988T3 (da) * 2010-05-25 2025-02-24 Memorial Sloan Kettering Cancer Center Fremgangsmåde til nociceptordifferentiering af humane embryonale stamceller og anvendelse heraf
BR112013008957A2 (pt) * 2010-10-15 2019-09-24 Univ Cornell composições e métodos para tratamento de doenças endócrinas, gastrointestinais ou autoimunes
EP3502236B1 (en) * 2011-02-18 2023-08-23 The Scripps Research Institute Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
EP2614829A1 (en) * 2012-01-11 2013-07-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Mammalian neural plate border stem cells capable of forming neural tube and neural crest cell lineages including central and peripheral neurons
KR20160033703A (ko) * 2013-07-23 2016-03-28 에프. 호프만-라 로슈 아게 체세포로부터 신경 능선 세포로의 소분자 기반 전환
WO2015017523A1 (en) * 2013-07-30 2015-02-05 Waters Technologies Corporation Check valve having polymeric seat and poppet
GB201318126D0 (en) * 2013-10-14 2013-11-27 Univ Cardiff Neuronal Stem Cell Differentiation
AU2014352773B2 (en) 2013-11-21 2021-04-29 Memorial Sloan-Kettering Cancer Center Specification of functional cranial placode derivatives from human pluripotent stem cells
CN114657141B (zh) * 2014-09-12 2025-02-25 京都府公立大学法人 雪旺氏细胞及其制备方法
US20180140637A1 (en) * 2015-05-19 2018-05-24 Maya Sieber-Blum Epidermal neural crest stem cells as a source of schwann cells
KR101903458B1 (ko) * 2017-01-20 2018-10-02 한국생명공학연구원 슈반 세포 전구체 (Schwann cell precursor) 및 이로부터 분화된 슈반 세포 (Schwann cell)의 제조 방법

Similar Documents

Publication Publication Date Title
JP2019535265A5 (https=)
Galiakberova et al. Neural stem cells and methods for their generation from induced pluripotent stem cells in vitro
Chang et al. Neurogenic differentiation of dental pulp stem cells to neuron-like cells in dopaminergic and motor neuronal inductive media
Lang et al. Differentiation of embryonic stem cells to a neural fate: a route to re‐building the nervous system?
Gorris et al. Pluripotent stem cell‐derived radial glia‐like cells as stable intermediate for efficient generation of human oligodendrocytes
Pollard et al. Adherent neural stem (NS) cells from fetal and adult forebrain.
Elkabetz et al. Human ESC-derived neural rosettes and neural stem cell progression
Erceg et al. Differentiation of human embryonic stem cells to regional specific neural precursors in chemically defined medium conditions
Dhara et al. Human neural progenitor cells derived from embryonic stem cells in feeder-free cultures
Yang et al. Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats
US8426200B2 (en) Neuronal differentiation of stem cells
Kim et al. Highly pure and expandable PSA-NCAM-positive neural precursors from human ESC and iPSC-derived neural rosettes
US10053667B2 (en) Differentiation of human pluripotent stem cells to multipotent neural crest cells
Gil et al. Vitronectin promotes oligodendrocyte differentiation during neurogenesis of human embryonic stem cells
JP2022546482A5 (https=)
CN102307990A (zh) 从干细胞衍生分化细胞的方法
Noisa et al. Neural progenitor cells derived from human embryonic stem cells as an origin of dopaminergic neurons
Lukovic et al. Highly efficient neural conversion of human pluripotent stem cells in adherent and animal-free conditions
Świerczek et al. From pluripotency to myogenesis: a multistep process in the dish
Kim et al. Neural induction of porcine‐induced pluripotent stem cells and further differentiation using glioblastoma‐cultured medium
JP2019503703A5 (https=)
US20080233649A1 (en) Pancreatic stem cells
Shimada et al. Differentiation of dopaminergic neurons from human embryonic stem cells: modulation of differentiation by FGF-20
Axell et al. A method for rapid derivation and propagation of neural progenitors from human embryonic stem cells
Shiraki et al. Differentiation and characterization of embryonic stem cells into three germ layers